Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Ter Heine

Showing results (21-30 of 160) with videos related to

Pageof 16
Sort By:
International Journal of Clinical Pharmacy|May 13, 2026
Deprescribing opportunities for patients with advanced non-small cell lung cancer: an observational study of potentially inappropriate medications and stakeholders' perspectivesFenna de Vries, Eva Verbeek, Arthur Smit, et al.
European Journal of Pediatrics|March 19, 2022
Lactate infusion as therapeutical intervention: a scoping reviewLoes A van Gemert, Bastiaan E de Galan, Ron A Wevers, et al.
British Journal of Clinical Pharmacology|February 1, 2018
A clinically relevant decrease in abiraterone exposure associated with carbamazepine use in a patient with castration-resistant metastatic prostate cancerGuillemette E Benoist, Maarten J van der Doelen, Rob Ter Heine, et al.
Antiviral Therapy|December 14, 2012
Therapeutic drug monitoring of antiretroviral drugs at home using dried blood spots: a proof-of-concept studyWiete Kromdijk, Jan W Mulder, Patrick M Smit, et al.
British Journal of Clinical Pharmacology|July 4, 2019
Nonlinear protein binding of phenytoin in clinical practice: Development and validation of a mechanistic prediction modelRob Ter Heine, Sean P Kane, Alwin D R Huitema, et al.
International Journal of Clinical Pharmacy|November 2, 2021
Variation in vancomycin dosing and therapeutic drug monitoring practices in neonatal intensive care unitsAnouk van der Veen, Annemie Somers, Sophie Vanhaesebrouck, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 17, 2016
Applying quality by design principles to the small-scale preparation of the bone-targeting therapeutic radiopharmaceutical rhenium-188-HEDPRogier Lange, Rob Ter Heine, Toon van der Gronde, et al.
Cancer Chemotherapy and Pharmacology|July 1, 2024
A sub-pharmacological test dose does not predict individual docetaxel exposure in prostate cancer patientsMarise R Heerma van Voss, Jessica Notohardjo, Joyce van Dodewaard-de Jong, et al.
Bone|August 7, 2016
Pharmaceutical and clinical development of phosphonate-based radiopharmaceuticals for the targeted treatment of bone metastasesRogier Lange, Rob Ter Heine, Russ Ff Knapp, et al.
Bioanalysis|May 19, 2011
Clinical evaluation of the determination of plasma concentrations of darunavir, etravirine, raltegravir and ritonavir in dried blood spot samplesRob Ter Heine, Jan W Mulder, Eric Cm van Gorp, et al.
Pageof 16

Showing results (21-30 of 160) with videos related to

Sort By:
Pageof 16
International Journal of Clinical Pharmacy|May 13, 2026
Deprescribing opportunities for patients with advanced non-small cell lung cancer: an observational study of potentially inappropriate medications and stakeholders' perspectivesFenna de Vries, Eva Verbeek, Arthur Smit, et al.
European Journal of Pediatrics|March 19, 2022
Lactate infusion as therapeutical intervention: a scoping reviewLoes A van Gemert, Bastiaan E de Galan, Ron A Wevers, et al.
British Journal of Clinical Pharmacology|February 1, 2018
A clinically relevant decrease in abiraterone exposure associated with carbamazepine use in a patient with castration-resistant metastatic prostate cancerGuillemette E Benoist, Maarten J van der Doelen, Rob Ter Heine, et al.
Antiviral Therapy|December 14, 2012
Therapeutic drug monitoring of antiretroviral drugs at home using dried blood spots: a proof-of-concept studyWiete Kromdijk, Jan W Mulder, Patrick M Smit, et al.
British Journal of Clinical Pharmacology|July 4, 2019
Nonlinear protein binding of phenytoin in clinical practice: Development and validation of a mechanistic prediction modelRob Ter Heine, Sean P Kane, Alwin D R Huitema, et al.
International Journal of Clinical Pharmacy|November 2, 2021
Variation in vancomycin dosing and therapeutic drug monitoring practices in neonatal intensive care unitsAnouk van der Veen, Annemie Somers, Sophie Vanhaesebrouck, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 17, 2016
Applying quality by design principles to the small-scale preparation of the bone-targeting therapeutic radiopharmaceutical rhenium-188-HEDPRogier Lange, Rob Ter Heine, Toon van der Gronde, et al.
Cancer Chemotherapy and Pharmacology|July 1, 2024
A sub-pharmacological test dose does not predict individual docetaxel exposure in prostate cancer patientsMarise R Heerma van Voss, Jessica Notohardjo, Joyce van Dodewaard-de Jong, et al.
Bone|August 7, 2016
Pharmaceutical and clinical development of phosphonate-based radiopharmaceuticals for the targeted treatment of bone metastasesRogier Lange, Rob Ter Heine, Russ Ff Knapp, et al.
Bioanalysis|May 19, 2011
Clinical evaluation of the determination of plasma concentrations of darunavir, etravirine, raltegravir and ritonavir in dried blood spot samplesRob Ter Heine, Jan W Mulder, Eric Cm van Gorp, et al.
Pageof 16